September 30, 2019 Bayer appoints Ingo Elfering Crop Science CIO and Head of Digital TransformationRead more
SPECIALIZED PRESS September 28, 2019 Not intended for U.S. and UK Media - European Society for Medical Oncology (ESMO) Congress 2019Updated analysis for larotrectinib confirms high response rate and durable responses over three years in children and adults with TRK fusion cancerRead more
September 24, 2019 Bayer, Brigham and Women’s Hospital, and Massachusetts General Hospital open joint lab for research of new treatments for chronic lung diseasesRead more
September 23, 2019 Not intended for U.S. and UK MediaVitrakvi® (larotrectinib) receives first tumor-agnostic approval in EURead more
SPECIALIZED PRESS September 20, 2019 Not intended for U.S. and UK Media - European Society for Medical Oncology (ESMO) Congress 2019Bayer data at ESMO 2019 highlights innovation in cancer researchRead more
September 17, 2019 Not intended for U.S. and UK MediaBayer and Informed Data Systems Inc. to develop One Drop digital therapeutics platform for multiple therapeutic areasRead more
September 11, 2019 Initiative offers financial support for novel approaches and enabling technologies in crop researchBayer opens application window for Grants4Traits™ and Grants4Biologicals™Read more
September 10, 2019 Changes to Board of Management structure as of January 1, 2020:Bayer reduces size of Board of Management from seven to five membersRead more
SPECIALIZED PRESS September 6, 2019 Bayer showcases Root2Success for potato and sweet potato growers at congress in Rwanda:Yields more than doubled during 4-year project with smallholder farmersRead more
.jpg)
